<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-ijms-22-01591">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Stead</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Faast</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Conn</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Goldstone</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rathjen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Dhingra</surname>
    <given-names>U.</given-names>
   </name>
   <name>
    <surname>Rathjen</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Walker</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Dalton</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities</article-title>
  <source>Oncogene</source>
  <year>2002</year>
  <volume>21</volume>
  <fpage>8320</fpage>
  <lpage>8333</lpage>
  <pub-id pub-id-type="doi">10.1038/sj.onc.1206015</pub-id>
  <pub-id pub-id-type="pmid">12447695</pub-id>
 </element-citation>
</ref>
